Oxford Technology 3rd Quarter Results
January 07 2022 - 8:00AM
UK Regulatory
TIDMOXT
Oxford Technology VCT Plc -- 3(rd) Quarter Results
Oxford Technology VCT Plc presents its quarterly update for the
3 month period commencing 1 September 2021.
The Directors have recently reviewed the valuation of its entire
portfolio as at 30 November 2021.
The unaudited net asset value per ordinary share as at 30
November 2021 was 50.3p. This represents a decrease of 1.1p from
the net asset value per ordinary share at 31 August 2021. This
decrease is mainly attributable to the fall in the share price of
Scancell Plc (22.5p to 20.0p), but partially offset by the increase
in the Arecor Therapeutics Plc share price (230p to 380p).
The total return to shareholders including previous dividends of
55.0p per share is now 105.3p per share.
The total number of ordinary shares in issue is 5,431,655.
The Directors are not aware of any other events or transactions
which have taken place between 30 November 2021 and the publication
of this statement which have had a material effect on the financial
position of the Company.
This announcement contains inside information as stipulated
under the UK version of the Market Abuse Regulation No 596/2014
which is part of English Law by virtue of the European (Withdrawal)
Act 2018, as amended. Upon the publication of this announcement via
a Regulatory Information Service, this information is now
considered to be in the public domain.
7 January 2022
Enquiries:
Lucius Cary, Oxford Technology Management
01865 784466
(END) Dow Jones Newswires
January 07, 2022 08:00 ET (13:00 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Oxford Technology Ventur... (LSE:OXT)
Historical Stock Chart
From May 2024 to Jun 2024
Oxford Technology Ventur... (LSE:OXT)
Historical Stock Chart
From Jun 2023 to Jun 2024